US Patent 7951931 Nucleic acid encoding sodium channel SCN3A alpha subunits
Patent 7951931 was granted and assigned to McGill on May, 2011 by the United States Patent and Trademark Office.
All edits
The present invention relates to epilepsy. More particularly, the present invention relates to idiopathic generalized epilepsy (IGE) and to the identification of three genes mapping to chromosome 2, which show mutations in patients with epilepsy. The invention further relates to nucleic acid sequences, and protein sequences of these loci (SCNA) and to the use thereof to assess, diagnose, prognose or treat epilepsy, to predict an epileptic individual's response to medication and to identify agents which modulate the function of the SCNA. The invention also provides screening assays using SCN1A, SCN2A and/or SCN3A which can identify compounds which have therapeutic benefit for epilepsy and related neurological disorders.
US Patent 07951931 Nucleic acid encoding sodium channel SCN3A alpha subunits US Patent 7951931 Nucleic acid encoding sodium channel SCN3A alpha subunits
US Patent 07951931 Nucleic acid encoding sodium channel SCN3A alpha subunits
Find more entities like US Patent 7951931 Nucleic acid encoding sodium channel SCN3A alpha subunits
